Company profile
Ticker
CYNA
Employees
Location
Fiscal year end
Industry (SIC)
Former names
Cynapsus Therapeutics Inc.
SEC CIK
Corporate docs
Latest filings (excl ownership)
CT ORDER
Confidential treatment order
17 Mar 20
15-12B
Securities registration termination
1 Nov 16
8-K
Amendments to Articles of Incorporation or Bylaws
24 Oct 16
25-NSE
Exchange delisting
21 Oct 16
8-K
Termination of a Material Definitive Agreement
21 Oct 16
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Oct 16
8-K
Cynapsus Therapeutics Obtains Final Court Order and HSR Waiting Period Expires for Plan of Arrangement with Sunovion Pharmaceuticals
18 Oct 16
8-K
Cynapsus Therapeutics Securityholders Approve the Plan of Arrangement with Sunovion Pharmaceuticals
13 Oct 16
8-K
Unregistered Sales of Equity Securities
11 Oct 16
8-K
Regulation FD Disclosure
29 Sep 16
Latest ownership filings
SC 13G/A
Sunovion CNS Development Canada Ulc
14 Feb 17
SC 13G/A
Sunovion CNS Development Canada Ulc
3 Feb 17
SC 13G/A
Sunovion CNS Development Canada Ulc
8 Dec 16
SC 13D/A
Cynapsus Therapeutics Inc.
21 Oct 16
SC 13G/A
Cynapsus Therapeutics Inc.
11 Oct 16
SC 13G/A
Cynapsus Therapeutics Inc.
16 Sep 16
SC 13D/A
Cynapsus Therapeutics Inc.
15 Sep 16
SC 13D
Cynapsus Therapeutics Inc.
12 Sep 16
SC 13G/A
Cynapsus Therapeutics Inc.
8 Jul 16
SC 13D
Cynapsus Therapeutics Inc.
16 Mar 16
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|